UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
Fusion Protein:DROSHA-DNAH5 |
Fusion Protein Summary |
Fusion gene summary |
Fusion partner gene information | Fusion gene name: DROSHA-DNAH5 | FusionPDB ID: 24169 | FusionGDB2.0 ID: 24169 | Hgene | Tgene | Gene symbol | DROSHA | DNAH5 | Gene ID | 29102 | 1767 |
Gene name | drosha ribonuclease III | dynein axonemal heavy chain 5 | |
Synonyms | ETOHI2|HSA242976|RANSE3L|RN3|RNASE3L|RNASEN | CILD3|DNAHC5|HL1|KTGNR|PCD | |
Cytomap | 5p13.3 | 5p15.2 | |
Type of gene | protein-coding | protein-coding | |
Description | ribonuclease 3RNase IIIdrosha, double-stranded RNA-specific endoribonucleasenuclear RNase III Droshap241putative protein p241 which interacts with transcription factor Sp1putative ribonuclease IIIribonuclease type III, nuclear | dynein heavy chain 5, axonemalaxonemal beta dynein heavy chain 5ciliary dynein heavy chain 5dynein, axonemal, heavy polypeptide 5 | |
Modification date | 20200313 | 20200327 | |
UniProtAcc | Q9NRR4 | Q8TE73 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000344624, ENST00000442743, ENST00000511367, ENST00000513349, ENST00000504361, | ENST00000504001, ENST00000265104, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 7 X 7 X 4=196 | 9 X 7 X 6=378 |
# samples | 7 | 8 | |
** MAII score | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(8/378*10)=-2.24031432933371 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: DROSHA [Title/Abstract] AND DNAH5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | DROSHA(31448654)-DNAH5(13931353), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | DROSHA-DNAH5 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. DROSHA-DNAH5 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. DROSHA-DNAH5 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. DROSHA-DNAH5 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. DROSHA-DNAH5 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. DROSHA-DNAH5 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. DROSHA-DNAH5 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DROSHA | GO:0031053 | primary miRNA processing | 14508493|15574589 |
Hgene | DROSHA | GO:0050829 | defense response to Gram-negative bacterium | 20180804 |
Hgene | DROSHA | GO:0050830 | defense response to Gram-positive bacterium | 20180804 |
Fusion gene breakpoints across DROSHA (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across DNAH5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Top |
Fusion Gene Sample Information |
Fusion gene information from FusionGDB2.0. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SKCM | TCGA-D3-A3CC-06A | DROSHA | chr5 | 31448654 | - | DNAH5 | chr5 | 13931353 | - |
Top |
Fusion ORF Analysis |
Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000513349 | DROSHA | chr5 | 31448654 | - | ENST00000265104 | DNAH5 | chr5 | 13931353 | - | 18611 | 3140 | 3146 | 16957 | 4603 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000513349 | ENST00000265104 | DROSHA | chr5 | 31448654 | - | DNAH5 | chr5 | 13931353 | - | 0.003901299 | 0.99609864 |
Top |
Fusion Amino Acid Sequences |
For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >24169_24169_1_DROSHA-DNAH5_DROSHA_chr5_31448654_ENST00000513349_DNAH5_chr5_13931353_ENST00000265104_length(amino acids)=4603AA_BP= MKGEKEAKRALLDARHNYLFAIVASCLDLNKTEVEDAILEGNQIERIDQLFAVGGLRHLMFYYQDVEEAETGQLGSLGGVNLVSGKIKKP KVFVTEGNDVALTGVCVFFIRTDPSKAITPDNIHQEVSFNMLDAADGGLLNSVRRLLSDIFIPALRATSHGWGELEGLQDAANIRQEFLS SLEGFVNVLSGAQESLKEKVNLRKCDILELKTLKEPTDYLTLANNPETLGKIEDCMKVWIKQTEQVLAENNQLLKEADDVGPRAELEHWK KRLSKFNYLLEQLKSPDVKAVLAVLAAAKSKLLKTWREMDIRITDATNEAKDNVKYLYTLEKCCDPLYSSDPLSMMDAIPTLINAIKMIY SISHYYNTSEKITSLFVKVTNQIISACKAYITNNGTASIWNQPQDVVEEKILSAIKLKQEYQLCFHKTKQKLKQNPNAKQFDFSEMYIFG KFETFHRRLAKIIDIFTTLKTYSVLQDSTIEGLEDMATKYQGIVATIKKKEYNFLDQRKMDFDQDYEEFCKQTNDLHNELRKFMDVTFAK IQNTNQALRMLKKFERLNIPNLGIDDKYQLILENYGADIDMISKLYTKQKYDPPLARNQPPIAGKILWARQLFHRIQQPMQLFQQHPAVL STAEAKPIIRSYNRMAKVLLEFEVLFHRAWLRQIEEIHVGLEASLLVKAPGTGELFVNFDPQILILFRETECMAQMGLEVSPLATSLFQK RDRYKRNFSNMKMMLAEYQRVKSKIPAAIEQLIVPHLAKVDEALQPGLAALTWTSLNIEAYLENTFAKIKDLELLLDRVNDLIEFRIDAI LEEMSSTPLCQLPQEEPLTCEEFLQMTKDLCVNGAQILHFKSSLVEEAVNELVNMLLDVEVLSEEESEKISNENSVNYKNESSAKREEGN FDTLTSSINARANALLLTTVTRKKKETEMLGEEARELLSHFNHQNMDALLKVTRNTLEAIRKRIHSSHTINFRDSNSASNMKQNSLPIFR ASVTLAIPNIVMAPALEDVQQTLNKAVECIISVPKGVRQWSSELLSKKKIQERKMAALQSNEDSDSDVEMGENELQDTLEIASVNLPIPV QTKNYYKNVSENKEIVKLVSVLSTIINSTKKEVITSMDCFKRYNHIWQKGKEEAIKTFITQSPLLSEFESQILYFQNLEQEINAEPEYVC VGSIALYTADLKFALTAETKAWMVVIGRHCNKKYRSEMENIFMLIEEFNKKLNRPIKDLDDIRIAMAALKEIREEQISIDFQVGPIEESY ALLNRYGLLIAREEIDKVDTLHYAWEKLLARAGEVQNKLVSLQPSFKKELISAVEVFLQDCHQFYLDYDLNGPMASGLKPQEASDRLIMF QNQFDNIYRKYITYTGGEELFGLPATQYPQLLEIKKQLNLLQKIYTLYNSVIETVNSYYDILWSEVNIEKINNELLEFQNRCRKLPRALK DWQAFLDLKKIIDDFSECCPLLEYMASKAMMERHWERITTLTGHSLDVGNESFKLRNIMEAPLLKYKEEIEDICISAVKERDIEQKLKQV INEWDNKTFTFGSFKTRGELLLRGDSTSEIIANMEDSLMLLGSLLSNRYNMPFKAQIQKWVQYLSNSTDIIESWMTVQNLWIYLEAVFVG GDIAKQLPKEAKRFSNIDKSWVKIMTRAHEVPSVVQCCVGDETLGQLLPHLLDQLEICQKSLTGYLEKKRLCFPRFFFVSDPALLEILGQ ASDSHTIQAHLLNVFDNIKSVKFHEKIYDRILSISSQEGETIELDKPVMAEGNVEVWLNSLLEESQSSLHLVIRQAAANIQETGFQLTEF LSSFPAQVGLLGIQMIWTRDSEEALRNAKFDKKIMQKTNQAFLELLNTLIDVTTRDLSSTERVKYETLITIHVHQRDIFDDLCHMHIKSP MDFEWLKQCRFYFNEDSDKMMIHITDVAFIYQNEFLGCTDRLVITPLTDRCYITLAQALGMSMGGAPAGPAGTGKTETTKDMGRCLGKYV VVFNCSDQMDFRGLGRIFKGLAQSGSWGCFDEFNRIDLPVLSVAAQQISIILTCKKEHKKSFIFTDGDNVTMNPEFGLFLTMNPGYAGRQ ELPENLKINFRSVAMMVPDRQIIIRVKLASCGFIDNVVLARKFFTLYKLCEEQLSKQVHYDFGLRNILSVLRTLGAAKRANPMDTESTIV MRVLRDMNLSKLIDEDEPLFLSLIEDLFPNILLDKAGYPELEAAISRQVEEAGLINHPPWKLKVIQLFETQRVRHGMMTLGPSGAGKTTC IHTLMRAMTDCGKPHREMRMNPKAITAPQMFGRLDVATNDWTDGIFSTLWRKTLRAKKGEHIWIILDGPVDAIWIENLNSVLDDNKTLTL ANGDRIPMAPNCKIIFEPHNIDNASPATVSRNGMVFMSSSILDWSPILEGFLKKRSPQEAEILRQLYTESFPDLYRFCIQNLEYKMEVLE AFVITQSINMLQGLIPLKEQGGEVSQAHLGRLFVFALLWSAGAALELDGRRRLELWLRSRPTGTLELPPPAGPGDTAFDYYVAPDGTWTH WNTRTQEYLYPSDTTPEYGSILVPNVDNVRTDFLIQTIAKQGKAVLLIGEQGTAKTVIIKGFMSKYDPECHMIKSLNFSSATTPLMFQRT IESYVDKRMGTTYGPPAGKKMTVFIDDVNMPIINEWGDQVTNEIVRQLMEQNGFYNLEKPGEFTSIVDIQFLAAMIHPGGGRNDIPQRLK RQFSIFNCTLPSEASVDKIFGVIGVGHYCTQRGFSEEVRDSVTKLVPLTRRLWQMTKIKMLPTPAKFHYVFNLRDLSRVWQGMLNTTSEV IKEPNDLLKLWKHECKRVIADRFTVSSDVTWFDKALVSLVEEEFGEEKKLLVDCGIDTYFVDFLRDAPEAAGETSEEADAETPKIYEPIE SFSHLKERLNMFLQLYNESIRGAGMDMVFFADAMVHLVKISRVIRTPQGNALLVGVGGSGKQSLTRLASFIAGYVSFQITLTRSYNTSNL MEDLKVLYRTAGQQGKGITFIFTDNEIKDESFLEYMNNVLSSGEVSNLFARDEIDEINSDLASVMKKEFPRCLPTNENLHDYFMSRVRQN LHIVLCFSPVGEKFRNRALKFPALISGCTIDWFSRWPKDALVAVSEHFLTSYDIDCSLEIKKEVVQCMGSFQDGVAEKCVDYFQRFRRST HVTPKSYLSFIQGYKFIYGEKHVEVRTLANRMNTGLEKLKEASESVAALSKELEAKEKELQVANDKADMVLKEVTMKAQAAEKVKAEVQK VKDRAQAIVDSISKDKAIAEEKLEAAKPALEEAEAALQTIRPSDIATVRTLGRPPHLIMRIMDCVLLLFQRKVSAVKIDLEKSCTMPSWQ ESLKLMTAGNFLQNLQQFPKDTINEEVIEFLSPYFEMPDYNIETAKRVCGNVAGLCSWTKAMASFFSINKEVLPLKANLVVQENRHLLAM QDLQKAQAELDDKQAELDVVQAEYEQAMTEKQTLLEDAERCRHKMQTASTLISGLAGEKERWTEQSQEFAAQTKRLVGDVLLATAFLSYS GPFNQEFRDLLLNDWRKEMKARKIPFGKNLNLSEMLIDAPTISEWNLQGLPNDDLSIQNGIIVTKASRYPLLIDPQTQGKIWIKNKESRN ELQITSLNHKYFRNHLEDSLSLGRPLLIEDVGEELDPALDNVLERNFIKTGSTFKVKVGDKEVDVLDGFRLYITTKLPNPAYTPEISART SIIDFTVTMKGLEDQLLGRVILTEKQELEKERTHLMEDVTANKRRMKELEDNLLYRLTSTQGSLVEDESLIVVLSNTKRTAEEVTQKLEI SAETEVQINSAREEYRPVATRGSILYFLITEMRLVNEMYQTSLRQFLGLFDLSLARSVKSPITSKRIANIIEHMTYEVYKYAARGLYEEH KFLFTLLLTLKIDIQRNRVKHEEFLTLIKGGASLDLKACPPKPSKWILDITWLNLVELSKLRQFSDVLDQISRNEKMWKIWFDKENPEEE PLPNAYDKSLDCFRRLLLIRSWCPDRTIAQARKYIVDSMGEKYAEGVILDLEKTWEESDPRTPLICLLSMGSDPTDSIIALGKRLKIETR YVSMGQGQEVHARKLLQQTMANGGWALLQNCHLGLDFMDELMDIIIETELVHDAFRLWMTTEAHKQFPITLLQMSIKFANDPPQGLRAGL KRTYSGVSQDLLDVSSGSQWKPMLYAVAFLHSTVQERRKFGALGWNIPYEFNQADFNATVQFIQNHLDDMDVKKGVSWTTIRYMIGEIQY GGRVTDDYDKRLLNTFAKVWFSENMFGPDFSFYQGYNIPKCSTVDNYLQYIQSLPAYDSPEVFGLHPNADITYQSKLAKDVLDTILGIQP KDTSGGGDETREAVVARLADDMLEKLPPDYVPFEVKERLQKMGPFQPMNIFLRQEIDRMQRVLSLVRSTLTELKLAIDGTIIMSENLRDA LDCMFDARIPAWWKKASWISSTLGFWFTELIERNSQFTSWVFNGRPHCFWMTGFFNPQGFLTAMRQEITRANKGWALDNMVLCNEVTKWM KDDISAPPTEGVYVYGLYLEGAGWDKRNMKLIESKPKVLFELMPVIRIYAENNTLRDPRFYSCPIYKKPVRTDLNYIAAVDLRTAQTPEH -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr5:31448654/chr5:13931353) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
DROSHA | DNAH5 |
FUNCTION: Ribonuclease III double-stranded (ds) RNA-specific endoribonuclease that is involved in the initial step of microRNA (miRNA) biogenesis. Component of the microprocessor complex that is required to process primary miRNA transcripts (pri-miRNAs) to release precursor miRNA (pre-miRNA) in the nucleus. Within the microprocessor complex, DROSHA cleaves the 3' and 5' strands of a stem-loop in pri-miRNAs (processing center 11 bp from the dsRNA-ssRNA junction) to release hairpin-shaped pre-miRNAs that are subsequently cut by the cytoplasmic DICER to generate mature miRNAs. Involved also in pre-rRNA processing. Cleaves double-strand RNA and does not cleave single-strand RNA. Involved in the formation of GW bodies. {ECO:0000269|PubMed:10948199, ECO:0000269|PubMed:14508493, ECO:0000269|PubMed:15531877, ECO:0000269|PubMed:15565168, ECO:0000269|PubMed:15574589, ECO:0000269|PubMed:15589161, ECO:0000269|PubMed:16751099, ECO:0000269|PubMed:16906129, ECO:0000269|PubMed:17159994, ECO:0000269|PubMed:26027739, ECO:0000269|PubMed:26748718}. | FUNCTION: Force generating protein of respiratory cilia. Produces force towards the minus ends of microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Required for structural and functional integrity of the cilia of ependymal cells lining the brain ventricles. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000344624 | - | 20 | 33 | 1_212 | 960.6666666666666 | 1375.0 | Compositional bias | Note=Pro-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000344624 | - | 20 | 33 | 219_316 | 960.6666666666666 | 1375.0 | Compositional bias | Note=Arg-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000442743 | - | 19 | 32 | 1_212 | 923.6666666666666 | 1338.0 | Compositional bias | Note=Pro-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000442743 | - | 19 | 32 | 219_316 | 923.6666666666666 | 1338.0 | Compositional bias | Note=Arg-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000511367 | - | 22 | 35 | 1_212 | 960.6666666666666 | 1375.0 | Compositional bias | Note=Pro-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000511367 | - | 22 | 35 | 219_316 | 960.6666666666666 | 1375.0 | Compositional bias | Note=Arg-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000513349 | - | 22 | 35 | 1_212 | 923.6666666666666 | 1338.0 | Compositional bias | Note=Pro-rich |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000513349 | - | 22 | 35 | 219_316 | 923.6666666666666 | 1338.0 | Compositional bias | Note=Arg-rich |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 1435_1465 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 284_305 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 3195_3302 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 3426_3491 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 3732_3817 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 4392_4420 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 740_825 | 19.0 | 4625.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 1980_1987 | 19.0 | 4625.0 | Nucleotide binding | ATP | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 2262_2269 | 19.0 | 4625.0 | Nucleotide binding | ATP | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 1942_2164 | 19.0 | 4625.0 | Region | AAA 1 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 2224_2443 | 19.0 | 4625.0 | Region | AAA 2 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 2550_2803 | 19.0 | 4625.0 | Region | AAA 3 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 2916_3170 | 19.0 | 4625.0 | Region | AAA 4 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 3185_3482 | 19.0 | 4625.0 | Region | Stalk | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 3567_3797 | 19.0 | 4625.0 | Region | AAA 5 | |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 4012_4226 | 19.0 | 4625.0 | Region | AAA 6 |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000344624 | - | 20 | 33 | 1107_1233 | 960.6666666666666 | 1375.0 | Domain | Note=RNase III 2 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000344624 | - | 20 | 33 | 1260_1334 | 960.6666666666666 | 1375.0 | Domain | Note=DRBM |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000344624 | - | 20 | 33 | 876_1056 | 960.6666666666666 | 1375.0 | Domain | Note=RNase III 1 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000442743 | - | 19 | 32 | 1107_1233 | 923.6666666666666 | 1338.0 | Domain | Note=RNase III 2 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000442743 | - | 19 | 32 | 1260_1334 | 923.6666666666666 | 1338.0 | Domain | Note=DRBM |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000442743 | - | 19 | 32 | 876_1056 | 923.6666666666666 | 1338.0 | Domain | Note=RNase III 1 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000511367 | - | 22 | 35 | 1107_1233 | 960.6666666666666 | 1375.0 | Domain | Note=RNase III 2 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000511367 | - | 22 | 35 | 1260_1334 | 960.6666666666666 | 1375.0 | Domain | Note=DRBM |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000511367 | - | 22 | 35 | 876_1056 | 960.6666666666666 | 1375.0 | Domain | Note=RNase III 1 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000513349 | - | 22 | 35 | 1107_1233 | 923.6666666666666 | 1338.0 | Domain | Note=RNase III 2 |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000513349 | - | 22 | 35 | 1260_1334 | 923.6666666666666 | 1338.0 | Domain | Note=DRBM |
Hgene | DROSHA | chr5:31448654 | chr5:13931353 | ENST00000513349 | - | 22 | 35 | 876_1056 | 923.6666666666666 | 1338.0 | Domain | Note=RNase III 1 |
Tgene | DNAH5 | chr5:31448654 | chr5:13931353 | ENST00000265104 | 0 | 79 | 1_1941 | 19.0 | 4625.0 | Region | Stem |
Top |
Fusion Protein-Protein Interaction |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
Gene | PPI interactors |
Protein-protein interactors based on sequence similarity (STRING) |
Gene | STRING network |
DROSHA | |
DNAH5 |
- Retained interactions in fusion protein (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost interactions due to fusion (protein functional feature from UniProt). |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to DROSHA-DNAH5 |
Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to DROSHA-DNAH5 |
Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |